Ipilimumab生物仿制藥是一種重組人單克隆抗體,可與細(xì)胞毒性T淋巴細(xì)胞相關(guān)抗原4(CTLA-4)結(jié)合。Ipilimumab生物仿制藥是一種IgG 1 κ免疫球蛋白,分子量約為148 kDa。伊匹單抗生物仿制藥在哺乳動物(中國倉鼠卵巢)細(xì)胞培養(yǎng)物中生產(chǎn)。 伊匹單抗生物仿制藥-超低內(nèi)毒素該產(chǎn)品同種型對照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 0.1 EU/mg as determined by the LAL method 制劑:Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.